secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elicio Therapeutics, Inc. (ELTX)
CIK:        0001601485
Form:       8-K
Filed at:   2026-06-24T20:05:56+00:00
Accession:  0001601485-26-000050
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Elicio hosts KOL event on ELI-002 7P for metastatic mKRAS PDAC; no new data disclosed
--------------------------------------------------------------------------------

- Virtual KOL event on June 24, 2026 featured Dr. Zev Wainberg (UCLA) and Dr. Peter Hosein (U. Miami).
- Event discussed path forward for ELI-002 7P in metastatic mutant KRAS-driven pancreatic ductal adenocarcinoma.
- No specific clinical data, enrollment updates, or financial guidance were included in the filed material.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1601485/000160148526000050/0001601485-26-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1601485/000160148526000050/angn-20260624.htm
  HTML page:      https://secwatch.observer/filing/0001601485-26-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer